Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Menglin Bai"'
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-28 (2023)
Abstract Until the advent of immune checkpoint inhibitors (ICIs), definitive radiotherapy (RT) concurrently with chemotherapy was recommended for unresectable, locally advanced non-small cell lung cancer (LA-NSCLC). The trimodality paradigm with cons
Externí odkaz:
https://doaj.org/article/bab73e89d44a413a8ceab9cf67e9cd4e
Autor:
Menglin Bai, Leilei Wu, Mengyu Zhao, Peng Jin, Jingru Liu, Weiqing Wang, Xuetian Gao, Yanan Wang, Wei Chong, Jinming Yu, Hao Chen, Xue Meng
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 10, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/c871075128c045fda1569a82d1820e66
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe purpose of this study was to investigate the predictive value of tumor metabolic parameters in combination with secondary lymphoid metabolic parameters on positron emission tomography (PET)/computed tomography (CT) for immune checkpoint
Externí odkaz:
https://doaj.org/article/e1498837339d4db5871f47993534a81e
Autor:
Leilei Wu, Jingru Liu, Shasha Wang, Menglin Bai, Min Wu, Zhenhua Gao, Jianing Li, Jinming Yu, Jie Liu, Xue Meng
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
PurposeWe investigated the correlation of 18F-AlF-NOTAPRGD2 (18F-RGD) uptake during positron emission tomography (PET) with tumoral programmed death-ligand 1 (PD-L1) expression and explored its potential in immune checkpoint inhibitor treatment.Metho
Externí odkaz:
https://doaj.org/article/f7d90da1bc154fbdbc7b8bd4376a462d
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThe role of immune checkpoint inhibitors (ICIs) in NSCLC patients with EGFR mutations are controversial. In this study, we aim to investigate the therapeutic efficacy of ICIs alone or in combination in patients with EGFR mutated NSCLC in la
Externí odkaz:
https://doaj.org/article/0239dda662d544bc8aeeca94d1b64cf5
Publikováno v:
Cellular Physiology and Biochemistry, Vol 50, Iss 5, Pp 2004-2016 (2018)
Background/Aims: Non-small-cell lung carcinoma (NSCLC) is the leading cause of cancer death, with tumor metastasis being mainly responsible for lung cancer-associated mortality. Our previous studies have found that tubulin polymerization promoting pr
Externí odkaz:
https://doaj.org/article/1928127be47b460ebdf9212a2f365f49
Autor:
Leilei, Wu, Jingru, Liu, Shasha, Wang, Menglin, Bai, Min, Wu, Zhenhua, Gao, Jianing, Li, Jinming, Yu, Jie, Liu, Xue, Meng
Publikováno v:
Frontiers in endocrinology. 13
We investigated the correlation ofForty-two mice were subcutaneously injected with CMT-167 lung carcinoma cells. A total of 30 mice with good growth tumor and good general condition were selected.Thirty mice were scanned byHigher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24f4cddc301e3538cd8bcba4456a389f
https://pubmed.ncbi.nlm.nih.gov/35846323
https://pubmed.ncbi.nlm.nih.gov/35846323
Publikováno v:
Frontiers in immunology. 13
BackgroundThe role of immune checkpoint inhibitors (ICIs) in NSCLC patients with EGFR mutations are controversial. In this study, we aim to investigate the therapeutic efficacy of ICIs alone or in combination in patients with EGFR mutated NSCLC in la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d42e6dd0b0aca059ca24c095e9e5ea
https://pubmed.ncbi.nlm.nih.gov/35296087
https://pubmed.ncbi.nlm.nih.gov/35296087
Publikováno v:
Cancer letters. 520
Despite advances in immunotherapy, extensive challenges remain in its clinical application. Positron emission tomography (PET)/computed tomography (CT) is widely used in the diagnosis and follow-up of malignant tumors and in the prediction of treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f804aa3cf1d542fde800c9aeb38abac5
https://pubmed.ncbi.nlm.nih.gov/34237407
https://pubmed.ncbi.nlm.nih.gov/34237407
Autor:
Kai Cui, Li Pang, Zou Benkui, Zhendan Wang, Wang Huansheng, Yang Ou, Menglin Bai, Sheng Li, Jiasheng Bian, Xiaobin Xu
Publikováno v:
International Urology and Nephrology. 50:1801-1809
Detection of circulating tumor cells (CTCs) in cancer patients has diagnostic and prognostic importance. However, the clinical implications of CTC detection in patients with renal cell carcinoma (RCC) are still unclear. In this study, we investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7c97ac93c9ebb2ef56dfac0c46eec0
https://doi.org/10.1007/s11255-018-1954-2
https://doi.org/10.1007/s11255-018-1954-2